$RFAI

RF Acquisition Corp II reported a net loss of $103.39K for 3Q 2026, reversing from a net income of $1.06M a year earlier, due to higher costs. The company has not started operations and expects no revenue until after a business combination. Shareholders approved a combination with Nanyang, but closing is subject to conditions. Redemption requests were submitted for 3,956,323 shares, and the trust termination date was extended to November 15, 2026.

Karpus Management reduced its stake in RF Acquisition Corp II (RFAI) by 630,100 shares at $43.01 per share, a 38.91% decrease in its holding. The firm now holds 989,433 shares, representing 1.24% of its portfolio and 24.75% of RFAI's outstanding shares. RFAI, a blank check company, has a market cap of $274.51 million and a high PE ratio of 266.75. The stock has declined 23.51% since the transaction.

U.S. stocks were mixed Monday, with the Nasdaq Composite down 150 points. The Chicago Fed National Activity Index fell to -0.08 in July, suggesting economic slowdown. Expion360 (XPON) surged 133% after a $3.425M acquisition and a $9M share offering. CID HoldCo (DAIC) and Sadot Group (SDOT) also rose, while FLZH, RFAI, and KNRX declined.

RF Acquisition Corp II (RFAI) stock surged 398.9% to $65.60 in pre-market trading after shareholders approved its merger with Nanyang Biologics, valued at $1.5 billion. The deal is expected to close soon, with the new company listing on Nasdaq as NYB. Trading volume was 11 times the daily average, driven by the merger news.

Premarket trading on Friday shows significant moves in several stocks. RFAI surged 489% to $75.00, SUGP rose 46% to $4.04, and USDE climbed 18% to $4.72. Conversely, DFNS dropped 18% to $20.05, OSIS fell 15% to $186.47, and OPHC declined 11% to $8.21. These early swings may indicate momentum for the regular trading session.

RF Acquisition Corp II (RFAI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. On August 19, 2026, RF Acquisition Corp II, a Cayman Islands exempted company with limited liability (“ RFAC ”), held an extraordinary general meeting of shareholders (the “ Extraordinary General Meeting ”) in connec

RF Acquisition Corp II (RFAI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement As approved by the shareholders of RF Acquisition Corp II (the “ Company ” or “ RFAC ”), by ordinary resolution, at an extraordinary general meeting of shareholders held on August 12, 2026 (the “ Meeting ”), on August 12, 2026

This article provides an in-depth look at the price history of RF Acquisition Corp II Right (RFAIR) stock, including daily prices, trade data, and corporate actions. It details 52-week key points, new highs, and new lows, offering investors tools for historical data analysis and performance tracking. The content is provided by Barchart.com, which also offers various membership levels for enhanced data access.

Berkley W R Corp significantly increased its stake in RF Acquisition Corp II (RFAI) during Q3, acquiring 183,030 additional shares to total 937,845 shares, now representing 0.6% of its portfolio and valued at $10.07 million. Other institutional investors like Radcliffe Capital, Shaolin Capital, and Magnetar Financial have also initiated new positions, indicating growing interest. Despite increased institutional investment, the blank-check company (SPAC), formed in February 2024, faces negative analyst coverage with an average "Sell" rating.

Nanyang Biologics, a Singapore-based artificial intelligence drug discovery start-up, plans to list on the Nasdaq stock exchange in the first quarter of 2026 via a merger with a US-listed special-purpose acquisition company (SPAC), as US President Donald Trump vowed to impose hefty tariffs on ...